Journals / Turkish Neurosurgery / 2014 / Cilt: 24 - Sayı: 5

Hospital Universitario de Getafe, Spain. CIBER de Enfermedades Respiratorias, Spain

Hipofiz Adenomları ve Diğer Sellar Tümörlerin Uzun Süreli Takiplerinden Elde Edilen Prognostik Faktörler

Pages
679–687
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In acromegaly, pre-operative level of 850 ng/ml for IGF-1 was noted as a possible prognostic cut-off value.CoNCLusIoN: Long-term follow-up results of our study suggest that factors common to all sellar tumors including tumor type, tumor size, total resection, and cavernous sinus invasion and tumor type-specific factors including sex and hormone levels play important roles in the prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIm: Pituitary adenomas do not have a single factor of aggressive behavior or recurrence.
📊
Key Findings & Data:The objective of this study was to determine factors influencing the prognosis in pituitary adenomas.mATERIAL and mETHods: 243 patients who were operated between January 2000 and June 2012 were included in this retrospective study.
💡
Conclusion & Impact:In acromegaly, pre-operative level of 850 ng/ml for IGF-1 was noted as a possible prognostic cut-off value.CoNCLusIoN: Long-term follow-up results of our study suggest that factors common to all sellar tumors including tumor type, tumor size, total resection, and cavernous sinus invasion and tumor type-specific factors including sex and hormone levels play important roles in the prognosis.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

AIm: Pituitary adenomas do not have a single factor of aggressive behavior or recurrence. The objective of this study was to determine factors influencing the prognosis in pituitary adenomas.mATERIAL and mETHods: 243 patients who were operated between January 2000 and June 2012 were included in this retrospective study. Demographic data, age at diagnosis, date of diagnosis, date of operation, type of operation, post-operative medications, pre- and postoperative hormone levels, and MRI findings were evaluated in each patient. REsuLTs: The rate of total resection of sellar tumors was less than 50% in our patient population. The prognosis was better in cases with total resection. Tumor size was a poor prognostic factor in sellar tumors. Female sex was a poor prognostic factor in acromegaly and male sex in prolactinoma. The prognosis was worse in patients with cavernous sinus invasion. In acromegaly, pre-operative level of 850 ng/ml for IGF-1 was noted as a possible prognostic cut-off value.CoNCLusIoN: Long-term follow-up results of our study suggest that factors common to all sellar tumors including tumor type, tumor size, total resection, and cavernous sinus invasion and tumor type-specific factors including sex and hormone levels play important roles in the prognosis.

Özet

AmAÇ: Hipofiz adenomlarının agresif davranış gösterebileceğini veya nüks edebileceğini önceden belirleyebilecek uygun bir parametre bulunmamaktadır. Çalışmanın amacı, hipofiz adenomlu hastalarda prognozu hangi faktörlerin etkilediğini belirlemektir.yÖNTEm ve GEREÇLER: Ocak 2000 ve Haziran 2012 tarihleri arasında opere edilen 243 olgu bu retrospektif çalışmaya dahil edildi. Hastalar, demografik bilgiler, tanı yaşı, tanı tarihi, operasyon tarihi, operasyon tipi, operasyon sonrası aldıkları ilaç tedavileri, operasyon öncesi ve sonrası hipofiz hormonları ve MR bulguları açısından değerlendirildi.BuLGuLAR: Olgularda sellar bölge tümörlerinin total rezeksiyon oranının % 50'den daha az olduğu görüldü. Total rezeksiyon yapılan olguların prognozunun daha iyi olarak bulundu. Sellar tümörlerde büyüklüğün prognozu olumsuz etkilediği tespit edildi. Akromegalide kadın, prolaktinomada erkek cinsiyetin prognozu kötü idi. Kavernöz sinüs invazyonu olan hipofiz adenomu olgularında prognoz daha kötü olarak saptandı. Akromegalide preoperatif IGF-1 için 850 ng/ml değerinin prognoz açısından bir cut-off değeri olabileceği görüldü.soNuÇ: Çalışmamızdaki uzun süreli takiplerden vardığımız sonuçlara göre tümör çeşidi, tümör büyüklüğü, total rezeksiyon ve kavernöz sinüs invazyonu gibi bütün sellar tümörlerde ortak olan faktörler ile cinsiyet ve hormon düzeyleri özellikleri gibi tümör çeşitlerine spesifik faktörler prognozda önemli rol oynamaktadır.

🔖

Cite This Article

DİRİ, H., ÖZASLAN, E., KURTSOY, A., TUCER, B., ŞİMŞEK, Y., ÖZTÜRK, F., DURAK, A. C., BAYRAM, F. (2014). Hospital Universitario de Getafe, Spain. CIBER de Enfermedades Respiratorias, Spain. Turkish Neurosurgery, Cilt: 24 - Sayı: 5, 679–687. https://ajindex.com/articles/404904

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Alahmadi H, Dehdashti AR, Gentili F: Endoscopic endonasal surgery in recurrent and residual pituitary adenomas after microscopic resection. World Neurosurg 77(3-4):540-547, 2012 2. Arasho BD, Schaller B, Sandu N, Zenebe G: Gender-related differences in pituitary adenomas. Exp Clin Endocrinol Diabetes 117(10):567-572, 2009 3. Asa SL: Practical pituitary pathology: What does the pathologist need to know? Arch Pathol Lab Med 132:1231-1240, 2008 4. Beauregard C, Truong U, Hardy J, Serri O: Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58(1):86-91, 2003 5. Brochier S, Galland F, Kujas M Parker F, Gaillard S, Raftopoulos C, Young J, Alexopoulou O, Maiter D, Chanson P: Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: A study of 142 patients. European Journal of Endocrinology 163:193-200, 2010 6. Chang EF, Zada G, Sughrue ME, Wilson CB, Blevins LS, Kunwar S: Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas. Pituitary 13(3):223-229, 2010 7. Ferreira JE, de Mello PA, de Magalhães AV: Non-functioning pituitary adenomas: Clinical features and immunohistochemistry. Arq Neuropsiquiatr 63(4):1070-1078, 2005 8. Greenman Y, Ouaknine G, Veshchev I, Reider-Groswasser II, Segev Y, Stern N: Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: Markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 58(6):763- 769, 2003 9. Greenman Y, Stern N: Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23(5):625-638, 2009 10. Honegger J, Ernemann U, Psaras T, Will B: Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study. Acta Neurochir (Wien) 149(1):21-29, 2007 11. Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr, Vance ML: Endoscopic transsphenoidal surgery for acromegaly: Remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732-2740, 2011 12. Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB, Pieralli S, Giovanelli M: Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108(3):525-532, 2008 13. Messerer M, De Battista JC, Raverot G, Kassis S, Dubourg J, Lapras V, Trouillas J, Perrin G, Jouanneau E: Evidenc